Efficacy and safety of chinese herbal medicine for treating mild or moderate COVID-19: A systematic review and meta-analysis of randomized controlled trials and observational studies

Background: The coronavirus disease 2019 (COVID-19) is still a pandemic globally, about 80% of patients infected with COVID-19 were mild and moderate. Chinese herbal medicine (CHM) has played a positive role in the treatment of COVID-19, with a certain number of primary studies focused on CHM in man...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Hongfei, Li, Mengting, Tian, Chen, Lai, Honghao, Zhang, Yuqing, Shi, Jiaheng, Shi, Nannan, Zhao, Hui, Yang, Kehu, Shang, Hongcai, Sun, Xin, Liu, Jie, Ge, Long, Huang, Luqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504662/
https://www.ncbi.nlm.nih.gov/pubmed/36160412
http://dx.doi.org/10.3389/fphar.2022.988237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504662/
https://www.ncbi.nlm.nih.gov/pubmed/36160412
http://dx.doi.org/10.3389/fphar.2022.988237

Ejemplares similares